Text Size
S
M
L
Listen
Santen Global
menu
Patients
Healthcare Professionals
Careers
Investors
Listen
Tap on the left to use.
Who We Are
Message
Message from the CEO
Corporate Story
Corporate Story
CORE PRINCIPLE / Our Commitment
CORE PRINCIPLE / Our Commitment
Our Values
Our Values
History
History of Santen
Corporate Executives
Corporate Executives
Corporate Governance
Corporate Governance
Policies
Policies and Statements
Company Infomation
Overview / Map
Global Operation
What We Do
MTP & Santen 2030
Medium-term Management Plan
Santen 2030
Efforts to Enhance Patients' Satisfaction
Efforts to Enhance Product Safety
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Research & Development
Research & Development
The Ophthalmic Product Process: R&D
Clinical Trial Information
Partnering
Santen's Partnership
Our Partners
Partnering Contact
Production
Production
Safety and Quality Assurance
The Ophthalmic Production Process: Production
Sales & Marketing
Sales & Marketing
Our Stories
Sustainability
Sustainability
Our Sustainability Commitment
Sustainability at Santen
Social
Access to Healthcare
Research & Development in Ophthalmology
Product Quality & Safety
Supply Chain
Human Rights
Talent
Digital Transformation (DX)
Governance
Corporate Governance
Compliance
Ethical Marketing
Risk Management
Information Security
Environment
Environmental initiatives
Measures against Climate Change
Environmental Load Reduction
Biodiversity
Disclosures Based on the TCFD Recommendations
Inclusion
Inclusive Society Santen Promotes
Inclusion Starting from Blind Football
Together with Society
With Employees
Related Information
Participating in the UN Global Compact
Social Contribution Activities
Stakeholder Engagement
Environment Data (up-to-date)
Social Data (up-to-date)
Governance Data (up-to-date)
GRI Standards Content Index
Sustainability Library
External Assessment
News
News
Show All
Press Release
IR News
Information
HOME
News
2002
Press Release
2002 Press Release
RSS
Press Release
11.22.2002
Santen Completes Construction Work on North Building of its Nara Research and Development Center [PDF:29KB]
11.06.2002
Santen announces its financial results for the six months ended September 30, 2002 [PDF:15KB]
10.30.2002
Revision of Performance Forecasts [PDF: 21KB]
10.10.2002
Santen to Launch OTC Eye Drops "Sante Uruoi Contact" [PDF: 51KB]
09.30.2002
Revision of Performance Forecasts [PDF:25KB]
09.17.2002
Santen Introduces Dimple Bottles for Prescription Eye Drops [PDF:20KB]
09.03.2002
Annual Report 2002 is now available on this Web site.
08.23.2002
Santen to Launch OTC Eye Drops SANTE 40 [PDF:25KB]
08.21.2002
Santen Launches OPHTHAGREEN for Intravenous Injection 25mg, Fluorescein Fundus Angiography Contrast Medium [PDF:20KB]
07.19.2002
Santen to Launch OTC Eye Drops SANTE 40V [PDF:23KB]
07.08.2002
Santen's THIOLA Tablet 100 Obtains Additional Indication of Treating Cystinuria [PDF:10KB]
07.05.2002
Changes to Principal Shareholder [PDF:16KB]
07.01.2002
Santen to Transfer Marketing of THIOLA Tablets 100 to Merck Hoei [PDF:11KB]
05.28.2002
Stock Option (Warrant) [PDF:17KB]
05.28.2002
Revision Regarding Trading Unit of Company Stock [PDF:10KB]
05.28.2002
Santen and Koken Enter Into Agreement Concerning Marketing of KK-951, Lacrimal Canaliculus Closing Material for Treatment of Dry Eye Syndrome [PDF:72KB]
05.13.2002
Notice regarding Share Buyback [PDF:12KB]
05.01.2002
Management Change of U.S. Subsidiary Santen Incorporated [PDF:12KB]
04.11.2002
Santen Receives Manufacturing Approval for Ophthagreen for Intravenous Injection 25mg, Fluorescein Fundus Angiography Contrast Medium [PDF:13KB]
04.10.2002
Santen Completes Construction Work on Second Building of Shiga Plant [PDF:12KB]
03.27.2002
Sankyo and Santen Enter into Agreement on Development, Manufacture and Marketing of a New Glaucoma Remedy [PDF:12KB]
03.22.2002
Management Change of U.S. Subsidiary Santen Incorporated [PDF:16KB]
03.05.2002
se Santen Purchases Own Shares on Market by ToSTNet-2 [PDF:12KB]
03.04.2002
Santen Pharmaceutical to Purchase Own Shares on Market by ToSTNet-2 [PDF:10KB]
03.01.2002
Santen to Launch Sante DryCare [PDF:13KB]
02.26.2002
Santen to Buyback Own Shares [PDF:11KB]
02.15.2002
Santen to Launch "Sante de u plus E alfa" and "Sante de u Aqua" [PDF:14KB]
News Archive
